• HOME
  • FAQs
  • NEWS
  • FULL PRESCRIBING INFORMATION
  • About VETMEDIN
    • Dual-acting inodilator
    • VETMEDIN in CHF
    |
  • About CHF|
    • Signs of CHF
    • AVVI
    • DCM
    • Diagnosing CHF
  • Act Now – Use VETMEDIN|
    • CHF treatment
    • Importance of acting now
    • 2009 ACVIM consensus statement
  • VETMEDIN Efficacy|
    • VetSCOPE
    • QUEST
  • Safety and Dosing|
    • Record of safe use
    • Dosage
  • VETMEDIN Programs
    • Mobile Dog Heart Health Tour
    • Million Heart Challenge
    • Quest for Life
    • CE Meetings Program
  • Mobile Dog Heart Health Tour
    • Heart health tour route
    • Visit my clinic
  • Million Heart Challenge
  • Quest for Life
  • CE Meetings Program

USEFUL LINKS

  • VETMEDIN Full Prescribing
    Information
  • Cardiac Education Group
  • YourDogsHeart.com
  • Boehringer Ingelheim Vetmedica, Inc.
  • QUEST Efficacy Trial
  • American College of Veterinary
    Internal Medicine

CE Meetings Program

VETMEDIN is actively sponsoring dinner meetings throughout the country with 2 featured speakers from the cardiology specialty. These valuable meetings can bolster your knowledge of the diagnosis and treatment of canine heart disease, including congestive heart failure (CHF). See list of dates below.

This enlightening look at canine CHF is titled "Managing CHF - as easy as A, B, C, D." It is a FREE continuing education (CE) meeting* covering the latest expert views on classification, diagnosis, and treatment from the ACVIM. This seminar is only available for veterinarians. The presentation will last approximately 1 hour with a half hour reserved for questions and discussion. Plenty of hors d'oeuvres will be served during the registration hour prior to the presentation.

Contact your Boehringer Ingelheim sales representative for more details.

Date Cardiologist Location
8/2/2011 Dr. Andy Beardow Long Island + Holbrook, NY
8/3/2011 Dr. Andy Beardow Hartford, CT
8/4/2011 Dr. Andy Beardow Providence, RI
8/16/2011 Dr. Andy Beardow North Chicago, IL
8/17/2011 Dr. Andy Beardow South Chicago, IL
8/18/2011 Dr. Andy Beardow Buffalo, NY
8/23/2011 Dr. Andy Beardow Madison, WI
8/24/2011 Dr. Andy Beardow Milwaukee, WI
8/24/2011 Dr. Lori Drourr Eugene, OR
8/25/2011 Dr. Andy Beardow Traverse City, MI
9/1/2011 Dr. Lori Drourr Grand Rapids, MI
9/7/2011 Dr. Lori Drourr Sacramento, CA
9/13/2011 Dr. Lori Drourr Oakland / Berkeley / Richmond, CA
9/14/2011 Dr. Lori Drourr San Francisco, CA
9/17/2011 Dr. Andy Beardow IVECCS Breakfast session, Nashville, TN
10/4/2011 Dr. Lori Drourr Manhattan/Hermosa/Redondo Beach, CA
10/5/2011 Dr. Lori Drourr Laguna Beach / Mission Viejo, CA
10/11/2011 Dr. Lori Drourr Seattle, WA (A)
10/11/2011 Dr. Andy Beardow Cincinnati, OH
10/12/2011 Dr. Andy Beardow Dallas, TX
10/12/2011 Dr. Lori Drourr Seattle, WA (B)
10/13/2011 Dr. Andy Beardow Fort Worth, TX
10/18/2011 Dr. Andy Beardow Orlando, FL
10/19/2011 Dr. Andy Beardow Tampa, FL
10/19/2011 Dr. Lori Drourr San Jose, CA
11/1/2011 Dr. Andy Beardow West Palm Beach, FL
11/2/2011 Dr. Andy Beardow Miami Beach, FL
11/8/2011 Dr. Andy Beardow Norfolk, VA
11/10/2011 Dr. Andy Beardow Nashville, TN
11/15/2011 Dr. Lori Drourr San Diego, CA
11/15/2011 Dr. Andy Beardow Atlanta, GA (A)
11/16/2011 Dr. Andy Beardow Atlanta, GA (B)
11/16/2011 Dr. Lori Drourr Carlsbad, CA
12/6/2011 Dr. Lori Drourr Santa Monica/East LA/ Torrance, CA
12/7/2011 Dr. Lori Drourr San Fernando Valley, CA

* This program was submitted but not yet approved by AAVSB RACE program for 2 hours of continuing education in jurisdictions that recognize AAVSB RACE approval. Please contact the AAVSB RACE program if you have any questions/concerns about this program's validity or relevancy to the veterinary profession. Visionaire Research & Education, RACE provides #280.

Important safety information

VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricularvalvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.

Home Site Map Terms of Use Privacy Contact About Boehringer Ingelheim Vetmedica,Inc.
VETMEDIN is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc.
© 2011 Boehringer Ingelheim Vetmedica, Inc.